Ferrone S - Search Results

1

Defective HLA class I antigen processing machinery in cancer.

Cai L, Michelakos T, Yamada T, Fan S, Wang X, Schwab JH, Ferrone CR, Ferrone S. Cai L, et al. Among authors: ferrone s, ferrone cr. Cancer Immunol Immunother. 2018 Jun;67(6):999-1009. doi: 10.1007/s00262-018-2131-2. Epub 2018 Feb 27. Cancer Immunol Immunother. 2018. PMID: 29487978 Free PMC article.

2

Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10.

Maio M, Gulwani B, Tombesi S, Ferrone S. Maio M, et al. Among authors: ferrone s. Cancer Immunol Immunother. 1989;30(1):34-42. doi: 10.1007/BF01665028. Cancer Immunol Immunother. 1989. PMID: 2513111 Free PMC article.

3

Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions.

Indiveri F, Pierri I, Rogna S, Poggi A, Romano R, Tavano A, Ratto G, Motta G, Ferrone S. Indiveri F, et al. Among authors: ferrone s. Cancer Immunol Immunother. 1986;22(3):232-5. doi: 10.1007/BF00200038. Cancer Immunol Immunother. 1986. PMID: 2942252 Free PMC article.

4

Modulation by MHC class I antigens of the biology of melanoma cells. Non-immunological mechanisms.

Gattoni-Celli S, Calorini L, Simile MM, Ferrone S. Gattoni-Celli S, et al. Among authors: ferrone s. Melanoma Res. 1993 Aug;3(4):285-9. Melanoma Res. 1993. PMID: 8219762 Review.

5

Abnormalities in HLA class I antigen expression by melanoma cells: structural characterization and functional implications.

Gattoni-Celli S, Calorini L, Byers HR, Etoh T, Wang Z, Ferrone S. Gattoni-Celli S, et al. Among authors: ferrone s. J Invest Dermatol. 1993 Feb;100(2 Suppl):226S-230S. J Invest Dermatol. 1993. PMID: 8433012 Free article. No abstract available.

6

HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.

Vitale M, Rezzani R, Rodella L, Zauli G, Grigolato P, Cadei M, Hicklin DJ, Ferrone S. Vitale M, et al. Among authors: ferrone s. Cancer Res. 1998 Feb 15;58(4):737-42. Cancer Res. 1998. PMID: 9485029

7

Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.

Desai SA, Wang X, Noronha EJ, Kageshita T, Ferrone S. Desai SA, et al. Among authors: ferrone s. Cancer Res. 1998 Jun 1;58(11):2417-25. Cancer Res. 1998. PMID: 9622083

8

Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model.

Cormier JN, Panelli MC, Hackett JA, Bettinotti MP, Mixon A, Wunderlich J, Parker LL, Restifo NP, Ferrone S, Marincola FM. Cormier JN, et al. Among authors: ferrone s. Int J Cancer. 1999 Mar 1;80(5):781-90. doi: 10.1002/(sici)1097-0215(19990301)80:5<781::aid-ijc24>3.0.co;2-a. Int J Cancer. 1999. PMID: 10048982 Free PMC article.

9

Analysis by NMR spectroscopy of the structural homology between the linear and the cyclic peptide recognized by anti-human leukocyte antigen class I monoclonal antibody TP25.99*.

Moy FJ, Desai SA, Wang X, Noronha EJ, Zhou Q, Ferrone S, Powers R. Moy FJ, et al. Among authors: ferrone s. J Biol Chem. 2000 Aug 11;275(32):24679-85. doi: 10.1074/jbc.M003647200. J Biol Chem. 2000. PMID: 10825172 Free article.

Previously, we reported the identification of a cyclic and a linear peptide that inhibits mAb TP25.99 binding to the beta(2)-mu-associated and beta(2)-mu-free HLA class I heavy chains (S. A. Desai, X. Wang, E. J. Noronha, Q. Zhou, V. Rebmann, H. Grosse-Wilde, F. J. Moy, R. …

Previously, we reported the identification of a cyclic and a linear peptide that inhibits mAb TP25.99 binding to the beta(2)-mu-associated a …

10

Desai SA, Wang X, Noronha EJ, Zhou Q, Rebmann V, Grosse-Wilde H, Moy FJ, Powers R, Ferrone S. Desai SA, et al. Among authors: ferrone s. J Immunol. 2000 Sep 15;165(6):3275-83. doi: 10.4049/jimmunol.165.6.3275. J Immunol. 2000. PMID: 10975844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

938 results

Search Page

Filters